Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 2/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7167827 | 0.98 | KMT2A (0.38) | TDP1CYP3A4TSHRKMT2AMEN1 | |
| SCHEMBL9550554 | 0.88 | CA2 (0.38) | TDP1CYP3A4TSHRKMT2AMEN1 | |
| SCHEMBL12313461 | 0.88 | CA2 (0.38) | TDP1CYP3A4TSHRKMT2AMEN1 | |
| SCHEMBL9550556 | 0.87 | KDM4E (0.37) | TDP1CYP3A4TSHRKMT2AMEN1 | |
| SCHEMBL10581713 | 0.86 | CYP3A4 (0.36) | TDP1CYP3A4TSHRKMT2AMEN1 | |
| SCHEMBL30480022 | 0.83 | CYP11B1 (0.35) | TDP1CYP3A4KMT2ALMNAALDH1A1 | |
| Carbon Monoxide SCHEMBL10733903 | 0.83 | LMNA (0.36) | TSHRKMT2AMEN1LMNAALDH1A1 | |
| Formaldehyde SCHEMBL11358299 | 0.83 | LMNA (0.36) | TSHRKMT2AMEN1LMNAALDH1A1 | |
| Carbon Monoxide SCHEMBL11358295 | 0.82 | LMNA (0.35) | TSHRKMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL31081595 | 0.81 | CYP3A4 (0.36) | TDP1CYP3A4KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | claimed |
| EP-2981560-B1 | CURING OF LIQUID THERMOSETTING RESINS | REICHHOLD LLC 2 (US) | 2021-10-13 | — | — | EP | claimed |
| EP-2981560-A1 | CURING OF LIQUID THERMOSETTING RESINS | Reichhold, Inc. (US) | 2016-02-10 | — | — | EP | claimed |
| US-9068045-B2 | Curing of liquid thermosetting resins | REICHHOLD, INC. (US) | 2015-06-30 | — | — | US | claimed |
| WO-2014165425-A1 | CURING OF LIQUID THERMOSETTING RESINS | REICHHOLD, INC. (US) | 2014-10-09 | — | — | WO | claimed |
| US-20140303315-A1 | CURING OF LIQUID THERMOSETTING RESINS | Polynt Composites USA Inc. | 2014-10-09 | — | — | US | claimed |
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| EP-0949265-B1 | RADIOACTIVE TRANSITION METAL NITRIDE HETERO-COMPLEX | NIHON MEDIPHYSICS CO LTD (JP) | 2003-05-07 | — | — | EP | claimed |
| US-20020048549-A1 | Radioactive transition metal nitride heterocomplex | DUATTI ADRIANO (IT) | 2002-04-25 | — | — | US | claimed |
| EP-0949265-A1 | RADIOACTIVE TRANSITION METAL NITRIDE HETERO-COMPLEX | Nihon Medi-Physics Co., Ltd. (JP) | 1999-10-13 | — | — | EP | claimed |
| EP-0309056-A1 | Process for the hydroformylation of olefins | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-03-29 | — | — | EP | claimed |
| JP-1113332-A | — | — | None | — | — | JP | disclosed |
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | disclosed |
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-06-01 | — | — | US | disclosed |
| US-5177253-A | Process for the preparation of alpha,beta-olefinically unsaturated compounds | SHELL OIL COMPANY (US) | 1993-01-05 | — | — | US | disclosed |
| JP-H01113332-A | HYDROFORMYLATING METHOD OF OLEFIN | SHELL INTERNATL RES MAATSCHAPPIJ BV | 1989-05-02 | — | — | JP | disclosed |
| EP-0309056-A1 | Process for the hydroformylation of olefins | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-03-29 | — | — | EP | disclosed |
| EP-0309056-A1 | Process for the hydroformylation of olefins | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | KRT18, CKAP4, VIM | TDP1 3775/4885CYP3A4 4371/4885TSHR 4711/4885 |
| US-20020048549-A1 | Radioactive transition metal nitride heterocomplex | SHBG, GNRHR, PRMT5 | TDP1 1924/4885CYP3A4 2456/4885TSHR 46/4885 |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | TDP1 3996/4885CYP3A4 4442/4885TSHR 4245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.